[
    [
        {
            "time": "2018-06-15",
            "original_text": "Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix",
            "features": {
                "keywords": [
                    "HP",
                    "Party City",
                    "AbbVie",
                    "OncoSec Medical",
                    "Pulmatrix"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "retail",
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-03-10",
            "original_text": "AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study",
            "features": {
                "keywords": [
                    "AstraZeneca",
                    "Calquence",
                    "CLL",
                    "Study"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-04-20",
            "original_text": "iShares Core Dividend Growth ETF Experiences Big Inflow",
            "features": {
                "keywords": [
                    "iShares",
                    "Dividend Growth",
                    "ETF",
                    "Inflow"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "iShares Core Dividend Growth ETF Experiences Big Inflow",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-12",
            "original_text": "Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far",
            "features": {
                "keywords": [
                    "Worst-Performing",
                    "Stocks",
                    "2019"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 3,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 2,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-06-04",
            "original_text": "AbbVie to Present at the Goldman Sachs Global Healthcare Conference",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Goldman Sachs",
                    "Global Healthcare",
                    "Conference"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie to Present at the Goldman Sachs Global Healthcare Conference",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]